Abnormal expression of KIF20A has been observed in various cancers, including breast, pancreatic, glioma, hepatocellular carcinoma, esophageal squamous cell carcinoma, bladder, and prostate cancers [77,78]. This evidence concerns the gene KIF20A and glioma.